Back to team page

Leiah Verdone

Senior UX Researcher

Leiah brings a unique background in health sciences to every project. She has clinical work experience with patient groups in a variety of healthcare populations which adds invaluable insight into human factors and UX considerations of medical devices and other health-related technology and products. Her passion for the latest tech drives her curiosity and desire to find creative ways to solve existing problems. Leiah has a BS in Health Sciences from Aurora University.

Bold facts

Learn more about

Leiah

Something unique about you summed up in one sentence

I lived in three countries before the age of 7.

Your favorite part of working at Bold Insight

Literally everything. It’s an exciting work environment where you get to feel challenged and inspired, while still having fun and enjoying the company of cool people (and pups)!

In your spare time (or if you had spare time), you would absolutely do this:

Binge watch Korean dramas.

How long have you been in the UX field?

3+ years

You cannot start the day without doing this:

Ha! Opening your eyes. These trick questions can’t get past me…

Your favorite city in the world is...and why?

Seoul. The food, the people, and the overall vibe make it a must-revisit city for me.

Your ultimate celebrity dinner party guest list would include:

If it’s a maximum of 4 other guests, whichever 4 members of BTS are available at the time.

Long-term personal or professional goal?

One day I’d love to build my dream house or go on tour with a big-name performer as a backup dancer.

Read our team’s latest bold insights

The future of fan engagement: How do you measure goosebumps?

One of the CES presentations I attended was a panel in the sports technology track called, The Future of Fan Engagement. The panel discussed cutting-edge research in the sports tech market and perspectives on the relationship between emergent media technologies and...

read more

The time for a better UX in digital therapeutics is now

If history has shown that payer behavior tends to shift once a critical mass has been achieved, and we are on the precipice of achieving that critical mass for digital therapeutics, having a “user friendly solution” is about to replace “having a reimbursable solution” as the #1 factor affecting physician prescribing behavior.

read more